Argenica Therapeutics (ASX:AGN) Accounts Payable & Accrued Expense : A$1.19 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Argenica Therapeutics Accounts Payable & Accrued Expense?

Argenica Therapeutics's quarterly accounts payable & accrued expense declined from Dec. 2022 (A$1.30 Mil) to Jun. 2023 (A$1.18 Mil) but then increased from Jun. 2023 (A$1.18 Mil) to Dec. 2023 (A$1.19 Mil).

Argenica Therapeutics's annual accounts payable & accrued expense increased from Jun. 2021 (A$0.42 Mil) to Jun. 2022 (A$0.71 Mil) and increased from Jun. 2022 (A$0.71 Mil) to Jun. 2023 (A$1.18 Mil).

Argenica Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Argenica Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argenica Therapeutics Accounts Payable & Accrued Expense Chart

Argenica Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Accounts Payable & Accrued Expense

0.42

0.71

1.18

Argenica Therapeutics Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			0.04	0.71	1.30	1.18	1.19

Argenica Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Argenica Therapeutics (ASX:AGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argenica Therapeutics Ltd (ASX:AGN) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

117 Broadway, Unit 4, Nedlands, WA, AUS, 6009

Website

https://www.argenica.com.au

Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.

Argenica Therapeutics (ASX:AGN) Headlines

No Headlines